Endpoints NewsThe inside story of how SalioGen, a startup trying to wrangle ‘jumping genes’ to make medicines, fell apartSalioGen Therapeutics, led by Ray Tabibiazar, shut down after failing to perfect its bat-derived gene editing technology..6 hours ago